サマリー

末梢血管用デバイスの世界市場規模は、2021年の103億米ドルから2026年には134億米ドルに達すると予測され、2021年から2026年までのCAGRは5.3％と予想されています。この市場の成長は、高齢者人口の急増とそれに伴う末梢血管疾患の有病率の上昇、末梢血管処置に対する有利な償還シナリオ、製品承認数の増加、糖尿病有病率の上昇、タバコ消費率の上昇などが要因となっています。
予測期間中に最も高い成長を遂げる製品セグメント「血行力学的血流変更装置」。
製品に基づき、末梢血管デバイス市場は、血管形成術バルーン、血管形成術ステント、カテーテル、血管内動脈瘤修復ステントグラフト、下大静脈フィルター、プラーク修正デバイス、血行動態変更デバイス、その他の末梢血管デバイスに区分されます。塞栓防止装置セグメントは、予測期間中に最も高いCAGRで成長すると予測されます。この市場の成長に寄与する主な要因は、新技術開発への投資の増加、これらのデバイスに対する規制当局の承認数の増加、および先進的なEPDの開発に対するベンチャーキャピタルの資金提供です。

"アジア太平洋地域は予測期間中に最も高いCAGRを記録すると推定される。"
本レポートでは、末梢血管機器市場を北米、欧州、アジア太平洋地域、その他の地域（RoW）の4つの主要地域セグメントに分けています。アジア太平洋地域の市場は、予測期間中に最も高い成長率を記録すると予測されます。この市場の成長は主に、高齢者人口の増加、低侵襲手術の利点に関する外科医の意識の高まり、およびいくつかのAPAC諸国における対象疾患の患者数の増加によってもたらされています。

供給側一次面接の内訳、企業タイプ別、呼称別、地域別。

- 企業タイプ別ティア1（32％）、ティア2（44％）、ティア3（24％）。

- 職位別Cレベル(30%)、ディレクターレベル(34%)、その他(36%)

- 地域別北米(40%)、欧州(28%)、アジア太平洋(20%)、その他の地域(12%)


レポート掲載企業一覧

- メドトロニック（アイルランド）
- ボストン・サイエンティフィック・コーポレーション（米国）
- アボット社（米国）
- ベクトン・ディッキンソン アンド カンパニー（米国）
- テルモ株式会社（日本）
- カーディナル・ヘルス社（米国）
- B. Braun Melsungen AG (米国)
- メリットメディカルシステムズ（米国）
- ペナンブラ社(米国)
- フィリップスN.V.( オランダ)
- iVascular S.L.U(スペイン)
- バイオセンサーズ・インターナショナル・グループ・リミテッド(シンガポール)
- BIOTRONIK (ドイツ)
- AMGインターナショナルGmbH（米国）
- ENDOCOR GmbH（ドイツ）
- メリル・ライフサイエンス社（Meril Life Sciences Pvt.(インド)
- アルビメディカ（トルコ）
- カーディオノバムGMBH（ドイツ）
- SMT（インド）
- メディノール社(イスラエル)
- Andramed GMBH（ドイツ）
- クック（米国）
- レックスメディカル（米国）
- デガニアシリコーン株式会社(イスラエル)
- ブロスメド・メディカル（中国）

研究範囲。
本レポートでは、製品別、地域別に末梢血管機器市場を調査しています。また、市場成長に影響を与える要因（促進要因、阻害要因、機会、課題など）を分析しています。利害関係者向けに市場の機会や課題を評価し、市場リーダー向けに競争環境の詳細を提供します。また、マイクロマーケットについては、その成長動向、展望、末梢血管機器市場全体への貢献度に関して調査しています。本レポートでは、5つの主要地域に関して、市場セグメントの収益を予測しています。


レポート購入の理由
本レポートは、以下のポイントに関する洞察を提供します。

- 市場の浸透度。末梢血管機器市場の上位25社が提供する末梢血管機器製品に関する包括的な情報。本レポートでは、末梢血管機器市場を製品別、地域別に分析しています。

- 市場の発展。有利な新興市場に関する包括的な情報。このレポートでは、主要な地域ごとの各種固定具の市場を分析しています。

- 市場の多様化。未開拓の地域、最近の開発、末梢血管機器市場への投資に関する徹底的な情報提供

- 競合の評価。末梢血管機器市場における主要企業の市場シェアと戦略に関する詳細な評価

ページTOPに戻る

目次

1 INTRODUCTION 49
1.1 OBJECTIVES OF THE STUDY 49
1.2 MARKET DEFINITION 49
1.3 MARKET SCOPE 50
1.3.1 MARKET SEGMENTATION 50
1.3.2 YEARS CONSIDERED FOR THE STUDY 51
1.4 CURRENCY 51
1.5 LIMITATIONS 51
1.6 STAKEHOLDERS 52
1.7 SUMMARY OF CHANGES 52
2 RESEARCH METHODOLOGY 53
2.1 RESEARCH DATA 53
FIGURE 1 RESEARCH DESIGNS 53
2.1.1 SECONDARY DATA 54
2.1.1.1 Key data from secondary sources 54
2.1.2 PRIMARY DATA 55
FIGURE 2 PRIMARY SOURCES 55
2.1.2.1 Key data from primary sources 56
2.1.2.2 Key industry insights 57
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 57
2.2 MARKET SIZE ESTIMATION 58
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 58
2.2.1 GROWTH FORECAST 59
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 59
FIGURE 6 TOP-DOWN APPROACH 60
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 61
FIGURE 7 DATA TRIANGULATION METHODOLOGY 61
2.4 ASSUMPTIONS FOR THE STUDY 62
2.5 RISK ASSESSMENT 62
TABLE 1 RISKS 62
2.6 COVID-19 HEALTH ASSESSMENT 63
2.7 COVID-19 ECONOMIC ASSESSMENT 63
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 63
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 65
 
3 EXECUTIVE SUMMARY 66
FIGURE 10 ANGIOPLASTY STENTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 66
FIGURE 11 ENDOVASCULAR ANEURYSM REPAIR (EVAR) STENT GRAFTS MARKET,
BY TYPE, 2021 VS. 2026 (USD MILLION) 67
FIGURE 12 INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 67
FIGURE 13 CATHETERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 68
FIGURE 14 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 68
FIGURE 15 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 69
FIGURE 16 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 69
FIGURE 17 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 70
FIGURE 18 GEOGRAPHIC SNAPSHOT OF THE GLOBAL PERIPHERAL
VASCULAR DEVICES MARKET 71
4 PREMIUM INSIGHTS 72
4.1 PERIPHERAL VASCULAR DEVICES MARKET OVERVIEW 72
FIGURE 19 INCREASING PREVALENCE OF PERIPHERAL VASCULAR DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 72
4.2 PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE 72
FIGURE 20 DRUG-ELUTING STENT PRODUCTS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2021 72
4.3 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE OF ANGIOPLASTY STENT AND COUNTRY 73
FIGURE 21 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN PERIPHERAL VASCULAR DEVICES MARKET IN 2021 73
4.4 PERIPHERAL VASCULAR DEVICES MARKET: GEOGRAPHIC SNAPSHOT 74
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 74
5 MARKET OVERVIEW 75
5.1 INTRODUCTION 75
5.2 MARKET DYNAMICS 75
FIGURE 23 PERIPHERAL VASCULAR DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 75
5.2.1 DRIVERS 76
5.2.1.1 Rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral vascular diseases 76
TABLE 2 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 76
5.2.1.2 Favorable reimbursement scenario for peripheral vascular procedures 76
TABLE 3 REIMBURSEMENT FOR PERIPHERAL VASCULAR PROCEDURES IN THE US 77
5.2.1.3 Increased number of product approvals 77
TABLE 4 PRODUCT APPROVALS IN THE PERIPHERAL VASCULAR DEVICES MARKET, 2017–2021 78
5.2.1.4 Increased prevalence of diabetes 78
TABLE 5 DIABETES POPULATION, BY REGION, 2019 VS. 2030 79
5.2.1.5 Rising rate of tobacco consumption 79
TABLE 6 THE TOP 10 COUNTRIES WITH THE HIGHEST SMOKING RATE (2021) 79
5.2.1.6 Growth in the incidence of obesity 80
TABLE 7 OBESITY RATE IN THE DEVELOPED COUNTRIES (2021) 80
5.2.2 RESTRAINTS 80
5.2.2.1 Increased number of product failures and recalls 80
5.2.3 OPPORTUNITIES 81
5.2.3.1 High growth rate in the emerging markets 81
5.2.4 CHALLENGES 81
5.2.4.1 Rise in the availability of alternative treatments 81
5.2.4.2 Dearth of skilled professionals with expertise in peripheral vascular devices 82
5.2.5 IMPACT OF THE COVID-19 PANDEMIC ON THE PERIPHERAL VASCULAR DEVICES MARKET 82
5.3 RANGES/SCENARIOS 83
5.3.1 PERIPHERAL VASCULAR DEVICES MARKET 83
FIGURE 24 PESSIMISTIC SCENARIO 83
FIGURE 25 OPTIMISTIC SCENARIO 83
FIGURE 26 REALISTIC SCENARIO 84
5.4 VALUE CHAIN ANALYSIS 84
FIGURE 27 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE 84
5.5 SUPPLY CHAIN ANALYSIS 85
FIGURE 28 DIRECT DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES 86
5.6 PORTER’S FIVE FORCES ANALYSIS 86
5.6.1 THREAT OF NEW ENTRANTS 86
5.6.2 INTENSITY OF COMPETITIVE RIVALRY 86
5.6.3 BARGAINING POWER OF BUYERS 87
5.6.4 BARGAINING POWER OF SUPPLIERS 87
5.6.5 THREAT OF SUBSTITUTES 87
5.7 TECHNOLOGY ANALYSIS 87
5.8 REGULATORY ANALYSIS 88
5.9 PATENT ANALYSIS 89
5.10 TRADE ANALYSIS 90
TABLE 8 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SERVICES, BY COUNTRY, 2016–2020 (USD MILLION) 90
TABLE 9 EXPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SERVICES, BY COUNTRY, 2016–2020 (USD MILLION) 90
TABLE 10 IMPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY PROCEDURES, BY COUNTRY, 2016–2020 (USD MILLION) 91
TABLE 11 EXPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY PROCEDURES, BY COUNTRY, 2016–2020 (USD MILLION) 91
5.11 PRICING ANALYSIS 92
TABLE 12 PRICE RANGE FOR PERIPHERAL VASCULAR DEVICES 92
5.12 ECOSYSTEM MAPPING 92
5.12.1 ROLE IN ECOSYSTEM 93
FIGURE 29 KEY PLAYERS IN THE PERIPHERAL VASCULAR DEVICE ECOSYSTEM 93
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 94
5.13.1 REVENUE SHIFT AND REVENUE POCKETS FOR PERIPHERAL VASCULAR DEVICES MARKET 94
5.13.2 REVENUE SHIFT FOR PERIPHERAL VASCULAR DEVICES 94
6 ANGIOPLASTY BALLOONS MARKET, BY TYPE 95
6.1 INTRODUCTION 96
TABLE 13 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION) 96
TABLE 14 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION) 96
TABLE 15 ANGIOPLASTY BALLOONS MARKET, BY REGION, 2016–2020 (USD MILLION) 97
TABLE 16 ANGIOPLASTY BALLOONS MARKET, BY REGION, 2021–2026 (USD MILLION) 97
6.2 OLD/NORMAL BALLOONS 97
6.2.1 OLD/NORMAL BALLOONS TO DOMINATE THE ANGIOPLASTY
BALLOONS MARKET 97
TABLE 17 OLD/NORMAL ANGIOPLASTY BALLOONS MARKET, BY REGION,
2016–2020 (USD MILLION) 98
TABLE 18 OLD/NORMAL ANGIOPLASTY BALLOONS MARKET, BY REGION,
2021–2026 (USD MILLION) 98
6.3 DRUG-ELUTING BALLOONS 98
6.3.1 DRUG-ELUTING BALLOONS TO WITNESS THE HIGHEST GROWTH IN THE ANGIOPLASTY BALLOONS MARKET 98
TABLE 19 DRUG-ELUTING BALLOONS MARKET, BY REGION,
2016–2020 (USD MILLION) 99
TABLE 20 DRUG-ELUTING BALLOONS MARKET, BY REGION,
2021–2026 (USD MILLION) 99
6.4 CUTTING AND SCORING BALLOONS 99
6.4.1 USE OF CUTTING BALLOONS IS LIMITED SINCE MEDICATION IS CONSIDERED THE PRIMARY TREATMENT FOR ATHEROSCLEROSIS 99
TABLE 21 CUTTING AND SCORING BALLOONS MARKET, BY REGION,
2016–2020 (USD MILLION) 100
TABLE 22 CUTTING AND SCORING BALLOONS MARKET, BY REGION,
2021–2026 (USD MILLION) 100
 
7 ANGIOPLASTY STENTS MARKET, BY TYPE 101
7.1 INTRODUCTION 102
TABLE 23 ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 102
TABLE 24 ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 102
TABLE 25 ANGIOPLASTY STENTS MARKET, BY REGION, 2016–2020 (USD MILLION) 102
TABLE 26 ANGIOPLASTY STENTS MARKET, BY REGION, 2021–2026 (USD MILLION) 103
7.2 DRUG-ELUTING STENTS 103
7.2.1 DRUG-ELUTING STENTS TO WITNESS A HIGHER ADOPTION DUE TO THE REDUCED RESTENOSIS RATE 103
TABLE 27 DRUG-ELUTING STENTS MARKET, BY REGION, 2016–2020 (USD MILLION) 104
TABLE 28 DRUG-ELUTING STENTS MARKET, BY REGION, 2021–2026 (USD MILLION) 104
7.3 BARE-METAL STENTS 104
7.3.1 INCREASING USE OF DRUG-ELUTING STENTS TO RESTRAIN MARKET GROWTH 104
TABLE 29 BARE-METAL STENTS MARKET, BY REGION, 2016–2020 (USD MILLION) 105
TABLE 30 BARE-METAL STENTS MARKET, BY REGION, 2021–2026 (USD MILLION) 105
7.3.2 BARE-METAL STENTS, BY DELIVERY PLATFORM 105
TABLE 31 BARE-METAL STENTS MARKET, BY DELIVERY PLATFORM,
2016–2020 (USD MILLION) 105
TABLE 32 BARE-METAL STENTS MARKET, BY DELIVERY PLATFORM,
2021–2026 (USD MILLION) 106
7.3.2.1 Balloon-expandable stents 106
TABLE 33 BALLOON-EXPANDABLE STENTS MARKET, BY REGION,
2016–2020 (USD MILLION) 106
TABLE 34 BALLOON-EXPANDABLE STENTS MARKET, BY REGION,
2021–2026 (USD MILLION) 107
7.3.2.2 Self-expandable stents 107
TABLE 35 SELF-EXPANDABLE STENTS MARKET, BY REGION,
2016–2020 (USD MILLION) 107
TABLE 36 SELF-EXPANDABLE STENTS MARKET, BY REGION,
2021–2026 (USD MILLION) 108
8 CATHETERS MARKET, BY TYPE 109
8.1 INTRODUCTION 110
TABLE 37 CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 110
TABLE 38 CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 110
TABLE 39 CATHETERS MARKET, BY REGION, 2016–2020 (USD MILLION) 110
TABLE 40 CATHETERS MARKET, BY REGION, 2021–2026 (USD MILLION) 111
8.2 ANGIOGRAPHY CATHETERS 111
8.2.1 ANGIOGRAPHY CATHETERS TO DOMINATE THE CATHETERS MARKET 111
TABLE 41 ANGIOGRAPHY CATHETERS MARKET, BY REGION,
2016–2020 (USD MILLION) 112
TABLE 42 ANGIOGRAPHY CATHETERS MARKET, BY REGION,
2021–2026 (USD MILLION) 112
 
8.3 GUIDING CATHETERS 112
8.3.1 GUIDING CATHETERS TO ACCOUNT FOR THE SECOND-LARGEST SHARE OF THE CATHETERS MARKET 112
TABLE 43 GUIDING CATHETERS MARKET, BY REGION, 2016–2020 (USD MILLION) 113
TABLE 44 GUIDING CATHETERS MARKET, BY REGION, 2021–2026 (USD MILLION) 113
8.4 IVUS/OCT CATHETERS 113
8.4.1 IVUS/OCT CATHETERS SEGMENT TO REGISTER THE HIGHEST GROWTH RATE 113
TABLE 45 IVUS/OCT CATHETERS MARKET, BY REGION, 2016–2020 (USD MILLION) 114
TABLE 46 IVUS/OCT CATHETERS MARKET, BY REGION, 2021–2026 (USD MILLION) 114
9 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY TYPE 115
9.1 INTRODUCTION 116
TABLE 47 EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 116
TABLE 48 EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 116
TABLE 49 EVAR STENT GRAFTS MARKET, BY REGION, 2016–2020 (USD MILLION) 116
TABLE 50 EVAR STENT GRAFTS MARKET, BY REGION, 2021–2026 (USD MILLION) 117
9.2 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS 117
9.2.1 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS TO DOMINATE THE MARKET 117
TABLE 51 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION,
2016–2020 (USD MILLION) 118
TABLE 52 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION,
2021–2026 (USD MILLION) 118
9.3 THORACIC AORTIC ANEURYSM STENT GRAFTS 118
9.3.1 INCREASING INCIDENCE OF THORACIC AORTIC ANEURYSMS TO DRIVE MARKET GROWTH IN THE COMING YEARS 118
TABLE 53 THORACIC AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION,
2016–2020 (USD MILLION) 119
TABLE 54 THORACIC AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION,
2021–2026 (USD MILLION) 119
10 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE 120
10.1 INTRODUCTION 121
TABLE 55 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 121
TABLE 56 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 121
TABLE 57 INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2016–2020 (USD MILLION) 121
TABLE 58 INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2021–2026 (USD MILLION) 122
10.2 RETRIEVABLE FILTERS 122
10.2.1 RETRIEVABLE FILTERS SEGMENT TO REGISTER A HIGHER GROWTH RATE 122
TABLE 59 RETRIEVABLE INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2016–2020 (USD MILLION) 122
TABLE 60 RETRIEVABLE INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2021–2026 (USD MILLION) 123
 
10.3 PERMANENT FILTERS 123
10.3.1 RISKS ASSOCIATED WITH PERMANENT FILTERS TO HAMPER THEIR SALES DURING THE FORECAST PERIOD 123
TABLE 61 PERMANENT INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2016–2020 (USD MILLION) 123
TABLE 62 PERMANENT INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2021–2026 (USD MILLION) 124
11 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE 125
11.1 INTRODUCTION 126
TABLE 63 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 126
TABLE 64 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 126
TABLE 65 PLAQUE MODIFICATION DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 126
TABLE 66 PLAQUE MODIFICATION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 127
11.2 ATHERECTOMY DEVICES 127
11.2.1 INCREASING INCIDENCE OF ATHEROSCLEROSIS AS A RESULT OF THE RISING GLOBAL PREVALENCE OF OBESITY TO DRIVE THE MARKET 127
TABLE 67 ATHERECTOMY DEVICES MARKET, BY REGION, 2016–2020 (USD MILLION) 128
TABLE 68 ATHERECTOMY DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION) 128
11.3 THROMBECTOMY DEVICES 128
11.3.1 GROWING DVT INCIDENCE TO DRIVE THE ADOPTION OF THROMBECTOMY DEVICES 128
TABLE 69 THROMBECTOMY DEVICES MARKET, BY REGION, 2016–2020 (USD MILLION) 129
TABLE 70 THROMBECTOMY DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION) 129
12 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE 130
12.1 INTRODUCTION 131
TABLE 71 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 131
TABLE 72 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 131
12.2 EMBOLIC PROTECTION DEVICES 131
12.2.1 INCREASING INVESTMENTS IN NEW TECHNOLOGY AND INCREASING REGULATORY APPROVALS TO DRIVE MARKET GROWTH 131
TABLE 73 EMBOLIC PROTECTION DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 132
TABLE 74 EMBOLIC PROTECTION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 132
12.3 CHRONIC TOTAL OCCLUSION (CTO) DEVICES 133
12.3.1 INCREASING INVESTMENTS IN THE DEVELOPMENT OF CTO DEVICES TO DRIVE MARKET GROWTH 133
TABLE 75 CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 133
TABLE 76 CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 133
13 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE 134
13.1 INTRODUCTION 135
TABLE 77 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 135
TABLE 78 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 135
TABLE 79 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 136
TABLE 80 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 136
13.2 GUIDEWIRES 136
TABLE 81 GUIDEWIRES MARKET, BY REGION, 2016–2020 (USD MILLION) 137
TABLE 82 GUIDEWIRES MARKET, BY REGION, 2021–2026 (USD MILLION) 137
13.3 VASCULAR CLOSURE DEVICES 137
TABLE 83 VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 138
TABLE 84 VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 138
13.4 INTRODUCER SHEATHS 138
TABLE 85 INTRODUCER SHEATHS MARKET, BY REGION, 2016–2020 (USD MILLION) 139
TABLE 86 INTRODUCER SHEATHS MARKET, BY REGION, 2021–2026 (USD MILLION) 139
13.5 BALLOON INFLATION DEVICES 139
TABLE 87 BALLOON INFLATION DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 140
TABLE 88 BALLOON INFLATION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 140
14 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION 141
14.1 INTRODUCTION 142
TABLE 89 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 142
TABLE 90 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 142
14.2 NORTH AMERICA 143
FIGURE 30 NORTH AMERICA: MARKET SNAPSHOT 143
TABLE 91 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2016–2020 (USD MILLION) 144
TABLE 92 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION) 144
TABLE 93 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 144
TABLE 94 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 145
TABLE 95 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 145
TABLE 96 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 145
TABLE 97 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 146
TABLE 98 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 146
TABLE 99 NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 146
TABLE 100 NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 147
TABLE 101 NORTH AMERICA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 147
TABLE 102 NORTH AMERICA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 147
TABLE 103 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 147
TABLE 104 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 148
TABLE 105 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2016–2020 (USD MILLION) 148
TABLE 106 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2021–2026 (USD MILLION) 148
TABLE 107 NORTH AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2016–2020 (USD MILLION) 149
TABLE 108 NORTH AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2021–2026 (USD MILLION) 149
14.2.1 FAVORABLE REIMBURSEMENT SCENARIO TO ENSURE DEVICE
ADOPTION IN THE US 149
TABLE 109 US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION) 151
TABLE 110 US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION) 151
TABLE 111 US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 151
TABLE 112 US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 152
TABLE 113 US: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 152
TABLE 114 US: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 152
TABLE 115 US: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 153
TABLE 116 US: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 153
TABLE 117 US: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 153
TABLE 118 US: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 153
TABLE 119 US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 154
TABLE 120 US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 154
TABLE 121 US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 154
TABLE 122 US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 155
TABLE 123 US: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 155
TABLE 124 US: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 155
14.2.2 CANADA 156
14.2.2.1 Rising prevalence of target diseases to drive market growth 156
TABLE 125 CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 156
TABLE 126 CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 156
TABLE 127 CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 157
TABLE 128 CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 157
TABLE 129 CANADA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 157
TABLE 130 CANADA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 158
TABLE 131 CANADA: EVAR STENT GRAFTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 158
TABLE 132 CANADA: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 158
TABLE 133 CANADA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 159
TABLE 134 CANADA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 159
TABLE 135 CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 159
TABLE 136 CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 160
TABLE 137 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 160
TABLE 138 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 160
TABLE 139 CANADA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 161
TABLE 140 CANADA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 161
14.3 EUROPE 161
TABLE 141 EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY,
2016–2020 (USD MILLION) 162
TABLE 142 EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 162
TABLE 143 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 163
TABLE 144 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 163
TABLE 145 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 163
TABLE 146 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 163
TABLE 147 EUROPE: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 164
TABLE 148 EUROPE: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 164
TABLE 149 EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 164
TABLE 150 EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 164
TABLE 151 EUROPE: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 165
TABLE 152 EUROPE: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 165
TABLE 153 EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 165
TABLE 154 EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 165
TABLE 155 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 166
TABLE 156 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 166
TABLE 157 EUROPE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 166
TABLE 158 EUROPE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 167
14.3.1 GERMANY 167
14.3.1.1 Increase in geriatric and obese populations contribute to device demand 167
TABLE 159 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 168
TABLE 160 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 168
TABLE 161 GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 168
TABLE 162 GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 168
TABLE 163 GERMANY: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 169
TABLE 164 GERMANY: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 169
TABLE 165 GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 169
TABLE 166 GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 169
TABLE 167 GERMANY: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 170
TABLE 168 GERMANY: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 170
TABLE 169 GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 170
TABLE 170 GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 170
TABLE 171 GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 171
TABLE 172 GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 171
TABLE 173 GERMANY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 171
TABLE 174 GERMANY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 172
14.3.2 FRANCE 172
14.3.2.1 Incidence of PE and DVT to increase owing to the growth of France’s geriatric population 172
TABLE 175 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 173
TABLE 176 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 173
TABLE 177 FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 173
TABLE 178 FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 173
TABLE 179 FRANCE: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 174
TABLE 180 FRANCE: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 174
TABLE 181 FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 174
TABLE 182 FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 174
TABLE 183 FRANCE: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 175
TABLE 184 FRANCE: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 175
TABLE 185 FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 175
TABLE 186 FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 175
TABLE 187 FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 176
TABLE 188 FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 176
TABLE 189 FRANCE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 176
TABLE 190 FRANCE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 177
14.3.3 UK 177
14.3.3.1 Increasing incidence of peripheral vascular diseases to support market growth in the UK 177
TABLE 191 UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION) 178
TABLE 192 UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION) 178
TABLE 193 UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 178
TABLE 194 UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 179
TABLE 195 UK: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 179
TABLE 196 UK: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 179
TABLE 197 UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 179
TABLE 198 UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 180
TABLE 199 UK: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 180
TABLE 200 UK: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 180
TABLE 201 UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 180
TABLE 202 UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 181
TABLE 203 UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 181
TABLE 204 UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 181
TABLE 205 UK: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 182
TABLE 206 UK: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 182
14.3.4 SPAIN 182
14.3.4.1 Rising geriatric population to increase the demand for peripheral vascular devices 182
TABLE 207 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 183
TABLE 208 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 183
TABLE 209 SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 183
TABLE 210 SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 184
TABLE 211 SPAIN: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 184
TABLE 212 SPAIN: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 184
TABLE 213 SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 184
TABLE 214 SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 185
TABLE 215 SPAIN: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 185
TABLE 216 SPAIN: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 185
TABLE 217 SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 185
TABLE 218 SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 186
TABLE 219 SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 186
TABLE 220 SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 186
TABLE 221 SPAIN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 187
TABLE 222 SPAIN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 187
14.3.5 ITALY 187
14.3.5.1 Increasing health expenditure and rising diabetes prevalence to drive market growth 187
TABLE 223 ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 188
TABLE 224 ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 188
TABLE 225 ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 188
TABLE 226 ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 189
TABLE 227 ITALY: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 189
TABLE 228 ITALY: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 189
TABLE 229 ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 189
TABLE 230 ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 190
TABLE 231 ITALY: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 190
TABLE 232 ITALY: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 190
TABLE 233 ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 190
TABLE 234 ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 191
TABLE 235 ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 191
TABLE 236 ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 191
TABLE 237 ITALY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 192
TABLE 238 ITALY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 192
14.3.6 REST OF EUROPE 192
TABLE 239 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP) 193
TABLE 240 ROE: PERCENTAGE OF GERIATRIC POPULATION TO THE TOTAL POPULATION, BY COUNTRY, 2015 VS. 2030 (MILLION) 193
TABLE 241 ROE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 194
TABLE 242 ROE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 194
TABLE 243 ROE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 194
TABLE 244 ROE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 194
TABLE 245 ROE: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 195
TABLE 246 ROE: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 195
TABLE 247 ROE: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 195
TABLE 248 ROE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 196
TABLE 249 ROE: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 196
TABLE 250 ROE: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 196
TABLE 251 ROE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 196
TABLE 252 ROE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 197
TABLE 253 ROE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 197
TABLE 254 ROE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 197
TABLE 255 ROE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 198
TABLE 256 ROE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 198